Immunology
Scientists in Italy have reported the occurrence of spontaneous mutations in the constant regions of T-cell receptor beta chains of T lymphocytes obtained from two babies who underwent in utero stem cell transplantation due to severe combined immunodeficiency. The study found that hypermutation of the T-cell receptor genes may occur
Immunology
Researchers from France have demonstrated that Toxoplasma gondii antigen-pulsed dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. This novel cell-free vaccine, composed of DC exosomes, has shown promise in eliciting a systemic Th1-biased specific immune response and conferring protection against infection. The study highlights the potential
Cytology
A groundbreaking phase I/II clinical trial is underway to treat chronic lymphocytic leukemia (CLL) using an innovative immunotherapeutic approach. The trial, sponsored by the Center for Cell and Gene Therapy at Baylor College of Medicine and The Methodist Hospital, utilizes MaxCyte's MaxCyte GT cell loading system to
Cytology
A new study from Canada has found that human herpesvirus 8 (HHV-8) specific antibodies are detectable in hematopoietic stem cell transplant recipients using a peptide-based enzyme immunoassay. The study, published in the Journal of Clinical Microbiology, evaluated the seroprevalence of HHV-8 in 42 allogeneic SCT recipients from Canada and found
Cytology
Children who require intensive care after undergoing hematopoietic stem cell transplant (HSCT) face a high risk of mortality, according to a study published in Hematological Oncology. Researchers analyzed the outcomes of 125 pediatric HSCT recipients and identified several prognostic factors that predict survival and death. The study found that patients
Cytology
Researchers have developed an interleukin 12-engineered allogeneic cell vaccine that exhibits a remarkable 80% efficacy in preventing HER-2/neu transgenic breast cancer in mice. This breakthrough study, published in the journal Cancer Research, highlights the potential of immunotherapy in cancer prevention. The vaccine, engineered to release interleukin (IL)-12, has
Cytology
Researchers in China have successfully used a TCR DNA vaccine to induce a humoral immunoreaction in mice with T cell lymphoma. The study, published in Vaccine, found that mice vaccinated with the TCR DNA vaccine produced antibodies against the beta chain of T cell lymphoma, with the highest antibody titers
Cytology
Scientific surveys conducted by Canadian researchers have identified significant variability in current practices relating to cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada. The Centers for Disease Control (CDC) guidelines for prevention and management of cytomegalovirus disease after hematopoietic stem cell transplantation were compared to current practices
Cytology
A recent study from the United States has found a correlation between the dose of hematopoietic stem cells and the speed of immune reconstitution after stem cell transplant. The research, published in Blood, used a congenic transplantation model to test the effect of different stem cell doses on immune recovery.
Cytology
Researchers at St. Bartholomew's Hospital in London have investigated the effectiveness of a new chemotherapy regimen for advanced ovarian cancer. The treatment involves a combination of gemcitabine, carboplatin, and paclitaxel, along with peripheral blood progenitor cell support, administered every 10 days for six cycles. This approach has shown
Cytology
Scientists from the United States have discovered that adenovirus transduction can significantly enhance dendritic cell maturation, leading to a strong tumor antigen-specific T cell response. This breakthrough study, published in Journal of Immunotherapy, reveals that the use of adenovirus to engineer dendritic cells can lead to a more mature phenotype,
Cytology
Scientists in Switzerland, Denmark, and Australia have discovered that dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara (MVA) can transfer resistance against herpes simplex virus type I to naive one-week-old mice. This groundbreaking research, published in the Journal of Immunology, reveals the complex interplay between dendritic cells,
